An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder. [PDF]
Bai WZ, Zhou SY, Mou YY, Peng L, Li LL.
europepmc +1 more source
Mirabegron administration for the prevention of ureteral injuries during ureteral access sheath insertion. [PDF]
Ermiş O +6 more
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis. [PDF]
Kümmerli S +6 more
europepmc +1 more source
Mirabegron exhibits antibacterial and Immunomodulatory activities demonstrated by in vitro and in vivo studies. [PDF]
Ahmed EA, Abd-Eldayem AM.
europepmc +1 more source
Copper(II)-Catalyzed Selective CAr-H Bond Formylation: Synthesis of Dialdehyde Aniline. [PDF]
Guo S, Li Y, Fan W, Liu Z, Huang D.
europepmc +1 more source
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry): Protocol for an Open-Label Prospective Randomized Trial. [PDF]
Svendsen AM +7 more
europepmc +1 more source
Iridium-Catalyzed Enantioselective Alkene Hydroalkylation via a Heteroaryl-Directed Enolization-Decarboxylation Sequence. [PDF]
Jing C, Mao W, Bower JF.
europepmc +1 more source
<i>N</i>-(3-Chloro-4-hy-droxy-phen-yl)acetamide. [PDF]
Uppu RM, Fronczek FR.
europepmc +1 more source

